n-3 Fatty Acid and Its Metabolite 18-HEPE Ameliorate Retinal Neuronal Cell Dysfunction by Enhancing Müller BDNF in Diabetic Retinopathy
Open Access
- 5 February 2020
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 69 (4), 724-735
- https://doi.org/10.2337/db19-0550
Abstract
Diabetic retinopathy (DR) is a widespread vision-threatening disease, and neuroretinal abnormality should be considered as an important problem. Brain-derived neurotrophic factor (BDNF) has recently been considered as a possible treatment to prevent DR-induced neuroretinal damage, but how BDNF is upregulated in DR remains unclear. We found an increase in hydrogen peroxide (H2O2) in the vitreous of patients with DR. We confirmed that human retinal endothelial cells secreted H2O2 by high glucose, and H2O2 reduced cell viability of MIO-M1, Müller glia cell line, PC12D, and the neuronal cell line and lowered BDNF expression in MIO-M1, whereas BDNF administration recovered PC12D cell viability. Streptozocin-induced diabetic rats showed reduced BDNF, which is mainly expressed in the Müller glia cell. Oral intake of eicosapentaenoic acid ethyl ester (EPA-E) ameliorated BDNF reduction and oscillatory potentials (OPs) in electroretinography (ERG) in DR. Mass spectrometry revealed an increase in several EPA metabolites in the eyes of EPA-E–fed rats. In particular, an EPA metabolite, 18-hydroxyeicosapentaenoic acid (18-HEPE), induced BDNF upregulation in Müller glia cells and recovery of OPs in ERG. Our results indicated diabetes-induced oxidative stress attenuates neuroretinal function, but oral EPA-E intake prevents retinal neurodegeneration via BDNF in Müller glia cells by increasing 18-HEPE in the early stages of DR.Keywords
Funding Information
- Takeda Science Foundation (17K16963, 19K09988, 18K16922, 19K07357, 15H05904, 18H02627)
This publication has 60 references indexed in Scilit:
- Diabetic retinopathy: hyperglycaemia, oxidative stress and beyondDiabetologia, 2017
- Vision-Related Functional Burden of Diabetic Retinopathy Across Severity Levels in the United StatesJAMA Ophthalmology, 2017
- Mechanistic Insights into Pathological Changes in the Diabetic RetinaThe American Journal of Pathology, 2016
- Neurons Limit Angiogenesis by Titrating VEGF in RetinaCell, 2014
- Diabetic RetinopathyThe New England Journal of Medicine, 2012
- Early Retinal Damage in Experimental Diabetes: Electroretinographical and Morphological ObservationsExperimental Eye Research, 2002
- Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin.JCI Insight, 1998
- Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis.Diabetes, 1998
- Spatial frequency-selective losses with pattern electroretinogram in Type 1 (insulin-dependent) diabetic patients without retinopathyDiabetologia, 1990
- Electroretinogram in Diabetic RetinopathyAmerican Journal of Ophthalmology, 1962